Jun 19, 2026
14 MIN READ

How Much Weight Does the Average Person Lose on Wegovy?

Clinical trials show that people using Wegovy lose an average of 15% of their body weight over 68 weeks. PlexusDx compounded semaglutide injection delivers comparable results at a fraction of the cost, starting at $149 per month with no dose-based price increases.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 19, 2026
14 MIN READ

how much weight does the average person lose on wegovy? — PlexusDx GLP-1 education

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy has become synonymous with GLP-1 weight loss therapy, but its price tag and supply challenges leave many patients searching for alternatives. Research published in the New England Journal of Medicine demonstrates that semaglutide produces meaningful weight reduction in people with obesity or overweight conditions. PlexusDx delivers the same active ingredient through licensed 503A compounding pharmacies, making precision weight loss accessible across all 50 states without insurance requirements.

Clinical Trial Results: What Wegovy Users Actually Lose

The STEP clinical trial program tracked semaglutide's effectiveness over 68 weeks in over 4,500 participants. Participants receiving the highest dose of semaglutide lost an average of 22% of their starting body weight—roughly 50 pounds for a 230-pound person. By comparison, participants on placebo lost only 2.4% of their body weight, highlighting semaglutide's potency as a GLP-1 receptor agonist that reduces appetite and increases feelings of fullness.

Weight loss progression typically follows a consistent pattern across the first six months of treatment. Most patients experience gradual weight reduction starting in week 4, with the steepest losses occurring between weeks 12 and 24. Importantly, weight loss plateaus in many users by month 5, meaning continued results depend on maintaining consistent dosing and lifestyle choices rather than ongoing dose increases alone.

How Individual Results Vary: Factors Beyond the Medication

Not everyone loses the same amount of weight on semaglutide, even at identical doses. Genetics, baseline metabolic rate, diet adherence, physical activity level, and individual insulin sensitivity all influence outcomes. Someone with insulin resistance may experience faster initial weight loss than a metabolically healthier individual, while genetic variations in GLP-1 receptor expression can affect how efficiently a person's body responds to the medication.

PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways—including key variants in the GLP1R gene (rs6923761) and FTO gene (rs9939609) that influence weight regulation. Understanding these genetic insights helps predict which patients may respond optimally to semaglutide versus tirzepatide, and whether microdose protocols might suit your individual physiology better than standard dosing approaches.

Wegovy Cost vs. PlexusDx Compounded Semaglutide Pricing

Wegovy's brand name price averages $935 to $1,350 per month depending on dose and pharmacy, creating financial barriers for many weight loss candidates. Insurance coverage exists but requires prior authorization, high deductibles, and often covers only certain dose levels. PlexusDx compounded semaglutide injection starts at $149 per month and remains flat regardless of dose escalation—your dose may need to go up, but your price won't.

The medications are bioequivalent, meaning the active semaglutide molecule is identical; the difference lies in delivery method and manufacturing source. PlexusDx sources all medications from licensed 503A compounding pharmacies meeting strict USP standards. No membership fees, insurance requirements, or hidden costs apply. Patients can also pay using HSA or FSA funds, adding another layer of financial accessibility for those with qualified health savings accounts.

Timeline for Realistic Weight Loss Expectations

Expect modest results in the first two weeks as your body adjusts to GLP-1 signaling and appetite suppression begins. Weeks 3 through 12 typically show accelerating weight loss as doses increase and your body adapts to lower food intake and improved satiety. By month 4, most patients report loss of 5–10% of their starting weight, with continued gradual reductions through month 6 and beyond.

Maintenance phase begins around month 6 when weight loss naturally plateaus for many users. This doesn't indicate treatment failure; rather, your body has reached a new equilibrium where calorie intake and expenditure balance at a lower body weight. Continuing medication at maintenance dose prevents weight regain, which clinical data shows occurs rapidly after discontinuation. PlexusDx patients typically maintain results long-term when staying consistent with their prescribed protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight does the average person lose in the first month of Wegovy or semaglutide?

Most patients lose 2–5 pounds in the first month as appetite suppression develops and dose titration begins. Significant weight loss accelerates in months 2 and 3 once therapeutic doses are reached. Individual variation is substantial based on starting weight, diet compliance, and personal metabolism.

Can I lose more than 22% of my body weight on semaglutide?

Some patients exceed the STEP trial average of 22% weight loss, particularly those with higher baseline BMI or those who combine medication with structured diet and exercise. However, average data suggests most users plateau around 15–20% total weight loss by month 6. Genetic factors and insulin sensitivity significantly influence individual ceiling effects.

Why is PlexusDx semaglutide so much cheaper than Wegovy if it's the same medication?

PlexusDx uses licensed 503A compounding pharmacies instead of brand-name manufacturing, eliminating brand markup, advertising costs, and marketing expenses. Compounded semaglutide injection starts at $149 per month with no insurance required, HSA/FSA eligible, and no your dose may need to go up - your price won't increases. You're paying for the active medication and compounding service, not corporate overhead.

What if I don't lose weight on semaglutide—is it a medication failure?

True non-response to semaglutide is rare; more commonly, patients experience modest rather than dramatic results, or weight loss plateaus earlier than expected. PlexusDx's Precision Peptide Genetic Test can identify whether your genetic profile suggests better response to tirzepatide (dual GIP/GLP-1 agonist) or alternative peptide protocols. Genetic insights help optimize medication choice before committing to long-term treatment.

Does the Precision Peptide Genetic Test help predict my weight loss results?

Yes—the test analyzes 150+ genetic insights across 49 peptides and 14 pathways, including variants in GLP1R (appetite signaling), FTO (metabolic regulation), MC4R (satiety), and GIPR (incretin response). This data helps PlexusDx clinicians predict whether you'll respond optimally to semaglutide monotherapy or benefit from alternative compounds like tirzepatide or microdose protocols. The test costs $99 as an add-on after your first month of treatment.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves